hers and glp 1 Online GLP-1 Clinic Review Novo Nordisk Drops Hims &
Description
The FDA removed tirzepatide from the drug shortage list in December 2024 and semaglutide in February 2025, eliminating the primary legal basis for "essentially a copy" compounding of these substances
However, weight loss itselfa primary outcome of GLP-1 treatmentoften improves reflux symptoms
Anitschkow and S
Read Healios complete coverage of ADA 2025 here.
GLP-1 agonists are widely prescribed in the private sector, usually with no face-to-face interaction, followed by a brief letter to the GP to inform them that their patient is taking this medication
